Truist Raises Labcorp Price Target to $395 From $365
Truist maintained its Buy rating. Baird maintained its Outperform rating and raised its price target to $396.
Story updates
01:50:42 PM UTC
SquawkNews
LABCORP HOLDINGS INC.: UBS RAISES TARGET PRICE TO $420 FROM $380